Changes in the rate of leucine-rich glioma-inactivated 1 seropositivity during the COVID-19 lockdown
Several reports suggest autoantibody-associated neurologic conditions, such as autoimmune encephalitis and myelin-oligodendrocyte glycoprotein (MOG) antibody–associated diseases, may be triggered by the COVID-19 pandemic and associated vaccinations.1,2 Conversely, public health measures, including l...
Main Authors: | Handel, AE, Palace, J, Bateman, E, Waters, P, Irani, SR |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Medical Association
2023
|
Similar Items
-
Fatigue predicts quality of life after leucine-rich glioma-inactivated 1-antibody encephalitis
by: Binks, SNM, et al.
Published: (2024) -
Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy.
by: Irani, SR, et al.
Published: (2014) -
Fatigue predicts quality of life after leucine‐rich glioma‐inactivated 1‐antibody encephalitis
by: Sophie N. M. Binks, et al.
Published: (2024-04-01) -
Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis.
by: Naasan, G, et al.
Published: (2014) -
EEG characteristics of anti ⁃ leucine ⁃ rich glioma ⁃ inactivated 1 antibody ⁃ associated encephalitis
by: ZHANG Yi⁃fan, et al.
Published: (2023-12-01)